Target intelligence / Profile preview

Severe acute respiratory syndrome coronavirus 2 spike protein S2 subunit and non-receptor binding domain epitopes (SARS-CoV-2 S2/non-RBD)

Target
SARS-CoV-2 S2/non-RBD
Molecular classification
Viral fusion protein, Type I transmembrane glycoprotein, Viral surface protein
01

Overview

The SARS-CoV-2 spike protein S2 subunit and non-receptor binding domain (non-RBD) epitopes are essential components of the viral entry mechanism. The S2 subunit is responsible for the fusion of the viral envelope with the host cell membrane, a process triggered after the S1 subunit binds to the ACE2 receptor (UniProt P0DTC2). Unlike the highly variable receptor-binding domain (RBD), the S2 subunit and certain non-RBD regions like the N-terminal domain (NTD) are relatively conserved across different SARS-CoV-2 variants and other coronaviruses (Harvey et al., 2021). This conservation makes them attractive targets for broadly neutralizing antibodies and "universal" vaccine development. Monoclonal antibodies targeting the NTD, such as 4A8, or the S2 subunit, such as S2P6, work by preventing the conformational changes required for membrane fusion or by sterically hindering viral attachment (Chi et al., 2020; Pinto et al., 2021). Most current COVID-19 vaccines, including BNT162b2 and mRNA-1273, elicit an immune response against the entire spike protein, thereby generating antibodies that target these S2 and non-RBD epitopes. Understanding these regions is crucial for overcoming the challenges posed by viral escape mutations in the RBD. These epitopes provide a pathway for developing therapeutics that maintain efficacy against emerging variants of concern. Therapeutic intervention at these sites often involves blocking the transition from pre-fusion to post-fusion states. Overall, the S2 and non-RBD regions are pivotal for broad-spectrum immunity and long-term pandemic management.

Other names
SARS-CoV-2 S2 subunitSARS-CoV-2 spike protein N-terminal domainSARS-CoV-2 NTDSARS-CoV-2 fusion protein subunitSARS-CoV-2 spike protein S2 domain
02

Mechanism of action

Inhibition of viral-host membrane fusion, neutralization of viral infectivity by binding to conserved non-RBD regions, and prevention of spike protein conformational changes.

03

Biological functions

Membrane fusionViral entryHost cell attachmentProteolytic processing
04

Disease associations

COVID-19Infection
05

Safety considerations

Viral escape mutationsAntibody-dependent enhancement (ADE)Immune imprintingReduced neutralization potency compared to RBD-targeting antibodies
06

Interacting drugs

Sotrovimab

7 more in the full profile.

07

Biomarkers

Anti-S2 antibody titerAnti-NTD antibody titerSARS-CoV-2 viral loadS-protein specific T-cell response

Beyond the preview

Go deeper on Severe acute respiratory syndrome coronavirus 2 spike protein S2 subunit and non-receptor binding domain epitopes (SARS-CoV-2 S2/non-RBD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe acute respiratory syndrome coronavirus 2 spike protein S2 subunit and non-receptor binding domain epitopes (SARS-CoV-2 S2/non-RBD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call